IL150918A0 - Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production - Google Patents

Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production

Info

Publication number
IL150918A0
IL150918A0 IL15091802A IL15091802A IL150918A0 IL 150918 A0 IL150918 A0 IL 150918A0 IL 15091802 A IL15091802 A IL 15091802A IL 15091802 A IL15091802 A IL 15091802A IL 150918 A0 IL150918 A0 IL 150918A0
Authority
IL
Israel
Prior art keywords
ester
sebum production
dual inhibitors
inhibiting sebum
synthesis
Prior art date
Application number
IL15091802A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL150918A0 publication Critical patent/IL150918A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15091802A 2001-08-01 2002-07-25 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production IL150918A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30933601P 2001-08-01 2001-08-01

Publications (1)

Publication Number Publication Date
IL150918A0 true IL150918A0 (en) 2003-02-12

Family

ID=23197778

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15091802A IL150918A0 (en) 2001-08-01 2002-07-25 Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production

Country Status (11)

Country Link
US (1) US20030134898A1 (de)
EP (1) EP1281399A3 (de)
JP (1) JP2003104878A (de)
KR (1) KR20030013289A (de)
CN (1) CN1404829A (de)
CA (1) CA2395006A1 (de)
HU (1) HUP0202548A2 (de)
IL (1) IL150918A0 (de)
NZ (1) NZ520487A (de)
PL (1) PL355281A1 (de)
ZA (1) ZA200206032B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
ES2313065T3 (es) 2003-10-09 2009-03-01 Warner-Lambert Company Llc Composiciones farmaceuticas que comprenden derivados de malonamida para disminuir la produccion de sebo.
CA2592118C (en) 2004-12-23 2015-11-17 Deciphera Pharmaceuticals, Llc Urea derivatives as enzyme modulators
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
AU2008251723A1 (en) 2007-04-20 2008-11-20 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
KR20110099687A (ko) 2008-10-29 2011-09-08 데시페라 파마슈티칼스, 엘엘씨. 항-암과 항-증식성 활성을 나타내는 시클로프로판 아미드와 유사체
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
JP2019512009A (ja) 2016-02-16 2019-05-09 ザ・ユニバーシティ・オブ・クイーンズランド スルホニルウレアおよび関連化合物ならびにこれらの利用
GB201721185D0 (en) 2017-12-18 2018-01-31 Nodthera Ltd Sulphonyl urea derivatives
CA3089630A1 (en) 2018-01-31 2019-08-08 Deciphera Pharmaceuticals, Llc Combination therapy for the treatment of mastocytosis
SG11202007198WA (en) 2018-01-31 2020-08-28 Deciphera Pharmaceuticals Llc Combination therapy for the treatment of gastrointestinal stromal tumors
CN112672995A (zh) * 2018-08-15 2021-04-16 英夫拉索姆有限公司 新型磺酰胺脲化合物
WO2020249667A1 (en) 2019-06-12 2020-12-17 NodThera Limited Sulfonylurea derivatives and uses thereof
TW202122082A (zh) 2019-08-12 2021-06-16 美商迪賽孚爾製藥有限公司 治療胃腸道基質瘤方法
EP4013412A1 (de) 2019-08-12 2022-06-22 Deciphera Pharmaceuticals, LLC Ripretinib zur behandlung gastrointestinaler stromakarzinome
EP4084778B1 (de) 2019-12-30 2023-11-01 Deciphera Pharmaceuticals, LLC Formulierungen eines amorphen kinase-inhibitors und verwendungsverfahren dafür
EP4084779B1 (de) 2019-12-30 2024-10-09 Deciphera Pharmaceuticals, LLC Zusammensetzungen von 1-(4-brom-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorphenyl)-3-phenylharnstoff
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716175A (en) * 1987-02-24 1987-12-29 Warner-Lambert Company Saturated fatty acid amides as inhibitors of acyl-CoA:cholesterol acyltransferase
US5245068A (en) * 1990-10-30 1993-09-14 Warner-Lambert Company Oxysulfonyl carbamates
US5214206A (en) * 1990-11-07 1993-05-25 Warner-Lambert Company Aminosulfonyl urea acat inhibitors
US5254715A (en) * 1990-11-07 1993-10-19 Warner-Lambert Company Aminosulfonyl carbamates
US5198466A (en) * 1990-11-09 1993-03-30 Warner-Lambert Company Oxysulfonyl urea acat inhibitors
ZA938019B (en) * 1992-11-13 1995-04-28 Upjohn Co Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
US6133326A (en) * 1994-08-31 2000-10-17 Pfizer Inc Compositions and methods for decreasing sebum production
CA2398219A1 (en) * 2000-02-02 2001-08-09 Warner-Lambert Company Dual inhibitors of cholesterol ester and wax ester synthesis for sebaceous gland disorders
US6514489B1 (en) * 2000-06-30 2003-02-04 Medicis Pharmaceutical Corp. Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions
EP1357908A4 (de) * 2001-01-30 2009-07-15 Merck & Co Inc "acylsulfamide zur behandlung von fettleibigkeit, diabetes und lipidstörungen"

Also Published As

Publication number Publication date
CN1404829A (zh) 2003-03-26
KR20030013289A (ko) 2003-02-14
EP1281399A3 (de) 2004-02-11
ZA200206032B (en) 2004-02-10
HU0202548D0 (de) 2002-10-28
EP1281399A2 (de) 2003-02-05
NZ520487A (en) 2004-03-26
CA2395006A1 (en) 2003-02-01
US20030134898A1 (en) 2003-07-17
JP2003104878A (ja) 2003-04-09
HUP0202548A2 (hu) 2003-02-28
PL355281A1 (en) 2003-02-10

Similar Documents

Publication Publication Date Title
IL150918A0 (en) Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
HUP0300497A3 (en) Inhibitors of human phosphatidyl-inositol 3-kinase delta
EP1383743A4 (de) Duale inhibitoren von pde 7 und pde 4
IL163277A (en) Controlled synthesis of ziprasidone and compositions thereof
IL154017A0 (en) Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors
IL163863A0 (en) Form of presentation for3-Ä(2-äÄ4-(hexyloxycarbonylamino-imino-methyl)-phenylaminoÜmethylü-1-methyl-1H-benzimidaz
PL368850A1 (en) Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors
AU2002305205A1 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
ATE355836T1 (de) Inhibitoren der mucin-synthese
HK1080867A1 (en) Improved synthesis of cyproterone acetate
HK1077762A1 (zh) TFGß[轉化生長因子]的抑制劑
HK1067361A1 (en) Direct production of high purity fischer-tropsch wax
AU2002346548A8 (en) Regioisomerically pure oxochlorins and methods of synthesis
AU2002213422A1 (en) Synthesis of 2-hydroxymethylglutamic acid and congeners thereof
HUP0105011A3 (en) Synthesis method of nitroxymethylphenyl esters of aspirin derivatives
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
GB0220861D0 (en) Presentation of information
DZ3288A1 (en) Dual inhibitors of cholesteryl ester and wax ester synthesis for sebaceous gland disorders
HUP0401641A3 (en) Use of substituted diazonine derivatives as phosphorodiesterase iv inhibitors
AU2252101A (en) New synthesis of SPLA2 inhibitors
GB2375762B (en) Stereospecific synthesis of 2-hydroxy-4-phenyl-butyric acid esters
AU2002300319A1 (en) Dual inhibitors of wax ester and cholesteryl ester synthesis for inhibiting sebum production
CZ20012029A3 (cs) Přípravek se zlepąeným terapeutickým aplikačním rozsahem obsahující inhibitory nukleotidové syntézy
AU2050001A (en) Synthesis of indole-containing spla2 inhibitors
AU2001257253A1 (en) Asymmetric synthesis of piperazic acid and derivatives thereof